title: Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta.
abstract: Transforming growth factor-beta (TGF-beta) is a naturally occurring growth inhibitory polypeptide that arrests the cell cycle in middle to late G1 phase. Cells treated with TGF-beta contained normal amounts of cyclin E and cyclin-dependent protein kinase 2 (Cdk2) but failed to stably assemble cyclin E-Cdk2 complexes or accumulate cyclin E-associated kinase activity. Moreover, G1 phase extracts from TGF-beta-treated cells did not support activation of endogenous cyclin-dependent protein kinases by exogenous cyclins. These effects of TGF-beta, which correlated with the inhibition of retinoblastoma protein phosphorylation, suggest that mammalian G1 cyclin-dependent kinases, like their counterparts in yeast, are targets for negative regulators of the cell cycle.
authors: Department of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98104.
authors: A
authors: A
authors: Koff
authors: M
authors: M
authors: Ohtsuki
authors: K
authors: K
authors: Polyak
authors: J M
authors: JM
authors: Roberts
authors: J
authors: J
authors: Massagué
mesh_terms: D000818:Animals; D042846:CDC2-CDC28 Kinases; D002457:Cell Extracts; D002460:Cell Line; D051357:Cyclin-Dependent Kinase 2; D018844:Cyclin-Dependent Kinases; D016213:Cyclins / Q000378:metabolism* / Q000494:pharmacology; D004789:Enzyme Activation / Q000187:drug effects; D016193:G1 Phase; D008907:Mink; D010766:Phosphorylation; D011494:Protein Kinases / Q000378:metabolism*; D017346:Protein Serine-Threonine Kinases; D016160:Retinoblastoma Protein / Q000378:metabolism; D016212:Transforming Growth Factor beta / Q000494:pharmacology*
chemical_list: D002457:Cell Extracts; D016213:Cyclins; D016160:Retinoblastoma Protein; D016212:Transforming Growth Factor beta; D011494:Protein Kinases; D017346:Protein Serine-Threonine Kinases; D042846:CDC2-CDC28 Kinases; D051357:Cyclin-Dependent Kinase 2; D018844:Cyclin-Dependent Kinases